InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Profound Medical Corp.

PROF Clue Score51
Ontario, Canada Fiscal year ends December CIK 0001628808
$6.90 -0.14% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.90 −52.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Fiscal year 2019Revenue4.2Operating income−14.9Net income−15.2Fiscal year 2020Revenue7.3 +75.0%Operating income−18.9Net income−21.6EPS, diluted1.25Fiscal year 2021Revenue6.9 −5.9%Operating income−30.3Net income−30.7EPS, diluted1.50 +20.0%Fiscal year 2022Revenue6.7 −2.8%Operating income−32.1Net income−28.7EPS, diluted1.38 −8.0%Fiscal year 2023Revenue5.9 −11.7%Operating income−28.7Net income−28.3EPS, diluted1.34 −2.9%Fiscal year 2024Revenue9.7 +65.1%Operating income−33.1Net income−27.8EPS, diluted1.12 −16.4%Fiscal year 2025Revenue16.1 +65.3%Operating income−41.3Net income−42.6EPS, diluted1.41 +25.9%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 4.2 7.3 6.9 6.7 5.9 9.7 16.1
Growth +75.0% −5.9% −2.8% −11.7% +65.1% +65.3%
Operating income n/a −14.9 −18.9 −30.3 −32.1 −28.7 −33.1 −41.3
Net income n/a −15.2 −21.6 −30.7 −28.7 −28.3 −27.8 −42.6
Growth
EPS, diluted n/a n/a 1.25 1.50 1.38 1.34 1.12 1.41
Growth +20.0% −8.0% −2.9% −16.4% +25.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2018Fiscal year 2019Gross margin57.3%Operating margin−357.1%Net margin−364.7%Fiscal year 2020Gross margin47.6%Operating margin−258.3%Net margin−296.0%Fiscal year 2021Gross margin43.0%Operating margin−440.7%Net margin−446.7%Free cash flow margin−325.8%Fiscal year 2022Gross margin45.2%Operating margin−480.9%Net margin−429.1%Fiscal year 2023Gross margin74.3%Operating margin−485.7%Net margin−480.1%Fiscal year 2024Operating margin−339.4%Net margin−285.6%Fiscal year 2025Operating margin−256.3%Net margin−264.4%Free cash flow margin−238.4%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 57.3% 47.6% 43.0% 45.2% 74.3% n/a n/a
Operating margin n/a −357.1% −258.3% −440.7% −480.9% −485.7% −339.4% −256.3%
Net margin n/a −364.7% −296.0% −446.7% −429.1% −480.1% −285.6% −264.4%
Free cash flow margin n/a n/a n/a −325.8% n/a n/a n/a −238.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Fiscal year 2019Operating cash flow−15.1Fiscal year 2020Operating cash flow−20.6Fiscal year 2021Operating cash flow−22.4Capital expenditure−0.0Free cash flow−22.4Fiscal year 2022Operating cash flow−25.8Fiscal year 2023Operating cash flow−22.6Fiscal year 2024Operating cash flow−23.5Fiscal year 2025Operating cash flow−38.2Capital expenditure−0.2Free cash flow−38.4
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a −15.1 −20.6 −22.4 −25.8 −22.6 −23.5 −38.2
Capital expenditure n/a n/a n/a −0.0 n/a n/a n/a −0.2
Free cash flow n/a n/a n/a −22.4 n/a n/a n/a −38.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash22.5Total debt8.8Net cash (debt)13.7Shareholders’ equity19.6Debt to equity0.45Fiscal year 2019Cash14.8Total debt9.1Net cash (debt)5.7Shareholders’ equity14.4Debt to equity0.64Fiscal year 2020Cash83.9Shareholders’ equity97.4Fiscal year 2021Cash67.2Shareholders’ equity80.6Fiscal year 2022Cash46.5Total debt7.7Net cash (debt)38.8Shareholders’ equity52.6Debt to equity0.15Fiscal year 2023Cash26.2Total debt7.1Net cash (debt)19.1Shareholders’ equity31.2Debt to equity0.23Fiscal year 2024Cash54.9Total debt4.7Net cash (debt)50.3Shareholders’ equity60.4Debt to equity0.08Fiscal year 2025Cash59.7Total debt4.5Net cash (debt)55.2Shareholders’ equity66.4Debt to equity0.07
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 22.5 14.8 83.9 67.2 46.5 26.2 54.9 59.7
Total debt 8.8 9.1 n/a n/a 7.7 7.1 4.7 4.5
Net cash (debt) 13.7 5.7 n/a n/a 38.8 19.1 50.3 55.2
Shareholders’ equity 19.6 14.4 97.4 80.6 52.6 31.2 60.4 66.4
Debt to equity 0.45 0.64 n/a n/a 0.15 0.23 0.08 0.07

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 4.2 7.3 6.9 6.7 5.9 9.7 16.1
Growth +75.0% −5.9% −2.8% −11.7% +65.1% +65.3%
n/a 1.8 3.8 3.9 3.7 2.9 3.6 4.7
n/a 2.4 3.5 3.0 3.0 4.4 n/a n/a
Growth +45.4% −15.0% +2.3% +45.1%
n/a 9.4 9.9 15.3 14.7 14.4 n/a n/a
n/a 5.8 7.6 10.3 9.5 18.5 23.1 32.1
n/a −14.9 −18.9 −30.3 −32.1 −28.7 −33.1 −41.3
Growth
n/a −15.1 −21.6 −30.6 −28.4 −28.5 −27.8 −42.3
n/a 0.1 0.0 0.1 0.3 −0.1 −0.0 0.3
n/a −15.2 −21.6 −30.7 −28.7 −28.3 −27.8 −42.6
Growth
Per share
n/a n/a 1.25 1.50 1.38 1.34 1.12 1.41
n/a n/a 1.25 1.50 1.38 1.34 1.12 1.41
Growth +20.0% −8.0% −2.9% −16.4% +25.9%
10.0 11.1 17.3 20.5 20.8 21.2 24.8 30.2
n/a n/a n/a n/a n/a 21.2 24.8 30.2
Growth +16.9% +22.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 17.1% a year over five years, and earnings per share grew 2.4% a year.
  • Operating margin is up 2.0 points on five years ago, at -256.3%.
  • A net loss in 7 of 7 years on file.